Drug Shortage Report for VINORELBINE INJECTION

Last updated on 2020-01-16 History
Report ID 33098
Drug Identification Number 02265990
Brand name VINORELBINE INJECTION
Common or Proper name Vinorelbine Injection, USP 10 mg/mL
Company Name FRESENIUS KABI CANADA LTD
Market Status CANCELLED POST MARKET
Active Ingredient(s) VINORELBINE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5mL SD Vial
ATC code L01CA
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-12-14
Actual start date
Estimated end date Unknown
Actual end date 2018-01-17
Shortage status Resolved
Updated date 2020-01-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-01-16 French Compare
v9 2020-01-16 English Compare
v8 2018-02-12 French Compare
v7 2018-02-12 English Compare
v6 2018-01-17 French Compare
v5 2018-01-17 English Compare
v4 2017-12-15 French Compare
v3 2017-12-15 English Compare
v2 2017-12-15 English Compare
v1 2017-12-15 English Compare

Showing 1 to 10 of 10